# Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis

> **NCT01541904** · PHASE2 · WITHDRAWN · sponsor: **Laboratorios Sophia S.A de C.V.**

## Conditions studied

- Ocular Itching
- Ocular Allergy
- Seasonal Allergic Conjunctivitis
- Perennial Allergic Conjunctivitis
- Conjunctivitis, Allergic

## Interventions

- **DRUG:** PRO-118 Ophthalmic Solution 0.015%
- **DRUG:** PRO-118 Ophthalmic Solution 0.015 %
- **DRUG:** PRO-118 Ophthalmic Solution 0.020 %
- **DRUG:** PRO-118 Ophthalmic Solution 0.020 %
- **DRUG:** Placebo Ophthalmic Solution

## Key facts

- **NCT ID:** NCT01541904
- **Lead sponsor:** Laboratorios Sophia S.A de C.V.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-03
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Reformulation
- **Last updated:** 2018-10-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01541904

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01541904, "Efficacy and Safety of PRO-118 Ophthalmic Solution in Allergic Conjunctivitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01541904. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*